{"title":"前列腺特异性抗原(PSA)在临床上应该如何使用,是单独作为筛查试验,还是作为根治性手术后检测复发或残留疾病的试验?","authors":"L L Bilodeau","doi":"","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":80043,"journal":{"name":"Journal of the International Federation of Clinical Chemistry","volume":"6 2","pages":"46"},"PeriodicalIF":0.0000,"publicationDate":"1994-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"How should prostate specific antigen (PSA) be used clinically, as a screening test alone or as a test to detect recurrence or residual disease after radical surgery?\",\"authors\":\"L L Bilodeau\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":80043,\"journal\":{\"name\":\"Journal of the International Federation of Clinical Chemistry\",\"volume\":\"6 2\",\"pages\":\"46\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1994-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the International Federation of Clinical Chemistry\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the International Federation of Clinical Chemistry","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
How should prostate specific antigen (PSA) be used clinically, as a screening test alone or as a test to detect recurrence or residual disease after radical surgery?